<--- Back to Details
First PageDocument Content
Food and Drug Administration / Health / Prescription Drug User Fee Act / Pharmaceutical industry / Abbreviated New Drug Application / Generic drug / Hospira / Anda / Drug Price Competition and Patent Term Restoration Act / Pharmaceutical sciences / Pharmaceuticals policy / Pharmacology
Food and Drug Administration
Health
Prescription Drug User Fee Act
Pharmaceutical industry
Abbreviated New Drug Application
Generic drug
Hospira
Anda
Drug Price Competition and Patent Term Restoration Act
Pharmaceutical sciences
Pharmaceuticals policy
Pharmacology

Generic User Fee Coalition

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 231,95 KB

Share Document on Facebook

Similar Documents

Pharmacology / Biotechnology / Health care / Recombinant proteins / Pharmaceutical industry / Immunosuppressants / Amgen / Biosimilar / Etanercept / Filgrastim / Hospira / Generic drug

BIOLOGICS IN THE PRACTICE OF LAW LINDSAY KELLY* Biologics have come to occupy an increasingly important role in the medical industry, accounting for well over $200 billion in worldwide sales inNot surprisingly, bi

DocID: 1rrNB - View Document

Medical research / Health / Clinical research / Drug safety / Pharmaceutical industry / Drug discovery / Food and Drug Administration / Pharmacovigilance / Drug development / Hospira / Phases of clinical research / Covance

ZAI Lab announces appointment of Dr. James Yan as Executive Vice President of Early Development and Drug Safety Shanghai, China – October – Zai Lab Limited (Zai Lab), an innovative biotech company based in Ch

DocID: 1qDbm - View Document

American brands / United States patent law / Hospira / Bivalirudin / On-sale bar

United States Court of Appeals for the Federal Circuit ______________________ THE MEDICINES COMPANY, Plaintiff-Appellant

DocID: 1qAvA - View Document

Business / Economy / Pharmaceutical sciences / American brands / Pfizer / Hospira / Medivation / AbbVie Inc. / Allergan /  Plc / AstraZeneca / Pharmaceutical industry in India / Sanofi

April 29, Sanofi Rebuffed in $9.3 Billion Proposal to Acquire Medivation Sanofi has made a non­binding proposal to acquire Medivation, Inc., a San Francisco­based biopharmaceutical company, for

DocID: 1q9zg - View Document

Dosage forms / Morphinans / Substituted amphetamines / Hospira / Dihydrocodeine / Caspofungin

Products Approved in FY 2010: New Drugs Review Approval Date No. Category Brand Name

DocID: 1pe3I - View Document